Continued Safety and Performance of the TIVUS System
Phase 2
- Conditions
- Hypertension, Resistant to Conventional Therapy
- Interventions
- Device: TIVUS
- First Posted Date
- 2013-04-19
- Last Posted Date
- 2014-03-26
- Lead Sponsor
- Cardiosonic
- Target Recruit Count
- 80
- Registration Number
- NCT01835535
- Locations
- 🇦🇺
Royal Perth Hospital, Perth, Australia
© Copyright 2025. All Rights Reserved by MedPath